AVECTAS Leads €7.23 million Consortium Awarded Part Funding From Disruptive Technologies Innovation Fund
Share this article Share this article DUBLIN, April 22, 2021 /PRNewswire/ -- Irish cell engineering company, Avectas, is leading a consortium which will invest €7.23 million, including €4.4 million awarded under the Irish Government's Disruptive Technology Innovation Fund (DTIF), to develop a high-throughput scale of its proprietary cell engineering platform Solupore®. With consortium partners Bluebridge Technologies and NIBRT, the project expands Avectas' development towards commercialising an advanced large-scale, digitalised cell engineering platform optimised to manufacture 'off-the...